ReviewMolecular medicine reports2026
Advances in miR‑200c regulation of apoptosis, pyroptosis and autophagy in disease (Review).
Review in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MicroRNAs (miRNAs or miRs) represent conserved non‑coding RNAs responsible for the regulation of gene expression in a post‑transcriptional manner. The dysregulation of miRNAs often leads to disease development and progress. In particular, miR‑200c is one of the miR‑200 family members, which is found deregulated in various pathologies and involved in the process of cancer progression through its participation in different molecular signaling pathways. Initially, miR‑200c was regarded as an essential factor in metastases formation. Nevertheless, following the increase in knowledge about cell death signaling pathways, it became clear that miR‑200c participates in various types of cell death such as apoptosis, autophagy and pyroptosis. The present narrative review primarily discusses the molecular mechanisms through which miR‑200c regulates apoptosis, pyroptosis and autophagy and explores its potential therapeutic value.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.